Detection and quantitation of β-blockers in plasma and urine

Bioanalysis

Volumn 2, Issue 2, 2010, Pages 263-276

  Shrivastav, Pranav S ^a   Buha, Shailesh M ^a   Sanyal, Mallika ^b  

^a GUJARAT UNIVERSITY   (India)

^b ST XAVIER S COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; ALPRENOLOL; AMOSULALOL; AROTINOLOL; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BEVANTOLOL; BISOPROLOL; BOPINDOLOL; BUCINDOLOL; BUNOLOL; BUPRANOLOL; CARAZOLOL; CARTEOLOL; CARVEDILOL; CELIPROLOL; ESMOLOL; LABETALOL; LANDIOLOL; LEVOBUNOLOL; MEPINDOLOL; METIPRANOLOL; METOPROLOL; NADOLOL; NEBIVOLOL; OXPRENOLOL; PENBUTOLOL; PROPRANOLOL; UNINDEXED DRUG; BETA ADRENERGIC RECEPTOR;

CAPILLARY ELECTROCHROMATOGRAPHY; DERIVATIZATION; DOPING; DRUG BLOOD LEVEL; DRUG CLASSIFICATION; DRUG MONITORING; DRUG URINE LEVEL; ELECTROSPRAY MASS SPECTROMETRY; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTERMETHOD COMPARISON; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICELLAR ELECTROKINETIC CHROMATOGRAPHY; REVIEW; SOLID PHASE MICROEXTRACTION; SUPERCRITICAL FLUID CHROMATOGRAPHY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDATION PROCESS; ANALYSIS; ANIMAL; BLOOD; BLOOD ANALYSIS; CLASSIFICATION; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; URINALYSIS; URINE;

ADRENERGIC BETA-ANTAGONISTS; ANALYTIC SAMPLE PREPARATION METHODS; ANIMALS; BLOOD CHEMICAL ANALYSIS; HUMANS; RECEPTORS, ADRENERGIC, BETA; URINALYSIS;

EID: 79952511856     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.09.184     Document Type: Review

References (84)

1. Rang HP, Dale MM, Ritter JM, Moore P. Pharmacology. Churchill Livingstone, Elsevier, London, UK, 285-300 (2003).
2. Ong HT. b-blockers in hypertension and cardiovascular disease. BMJ 334, 946-949 (2007).
3. Weber MA. The role of new b-blockers in treating cardiovascular diseases. Am. J. Hypertens. 18, 169S-176S (2005).
4. Maurer HH, Tenberken O, Kratzsch C, Weber AA, Peters FT. Screening for library-assisted identification and fully validated quantification of 22 b-blockers in blood plasma by liquid chromatography-mass spectrometry with atmospheric pressure chemical ionization. J. Chromatogr. A 1058, 169-181 (2004). (Pubitemid 39487217)
5. Kataoka H, Narimatsu S, Lord HL, Pawliszyn J. Automated in-tube solid-phase microextraction coupled with liquid chromatography/electrospray ionization mass spectrometry for the determination of b-blockers and metabolites in urine and serum samples. Anal. Chem. 71, 4237-4244 (1999). (Pubitemid 29466403)
6. Rapado Martinez I, Villanueva Camanas RM, Garcia Alvarez-Coque MC. Micellar liquid chromatography: a worthy technique for the determination of b-antagonists in urine samples. Anal. Chem. 71, 319-326 (1999). (Pubitemid 129495305)
7. Badoud F, Grata E, Perrenoud L, et al. Fast analysis of doping agents in urine by ultra-high-pressure liquid chromatography- quadrupole time-of-flight mass spectrometry I. Screening analysis, J. Chromatogr. A 1216, 4423-4433 (2009).
8. Hu X, Pan J, Hu Y, Li G. Preparation and evaluation of propranolol molecularly imprinted solid-phase microextraction fibre for trace analysis of b-blockers in urine and plasma samples. J. Chromatogr. A 1216, 190-197 (2009).
9. Liu W, Zhang L, Wei Z, Chen S, Chen G. Analysis of b-agonists and b-blockers in urine using hollow fibre-protected liquid-phase micro-extraction with in-situ derivatization followed by gas chromatography-mass spectrometry. J. Chromatogr. A 1216, 5340-5346 (2009).
10. Buszewski B, Welerowicz T, Tegowska E, Krzeminski TF. Determination of selected b-receptor antagonists in biological samples by solid-phase extraction with cholesterolic phase and LC/MS. Anal. Bioanal. Chem. 393, 263-272 (2009). (Pubitemid 50266344)
11. Marchi I, Rudaz S, Veuthey JL. Sample preparation development and matrix effects evaluation for multianalyte determination in urine. J. Pharm. Biomed. Anal. 49, 459-467 (2009).
12. Thörngren JO, Östervall F, Garle M. A high-throughput multicomponent screening method for diuretics, masking agents, central nervous system (CNS) stimulants and opiates in human urine by UPLC-MS/MS. J. Mass Spectrom. 43, 980-992 (2008). (Pubitemid 352029667)
13. Ventura R, Roig M, Monfort N, Sáez P, Bergés R, Segura J. High-throughput and sensitive screening by ultra-performance liquid chromatography tandem mass spectrometry of diuretics and other doping agents. Eur. J. Mass Spectrom. 14, 191-200 (2008).
14. Lu M, Zhang L, Qui B, Feng Q, Xia S, Chen G. Rapid separation and sensitive detection method for b-blockers by pressure-assisted capillary electrochromatography-electrospray ionization mass spectrometry. J. Chromatogr. A 1193, 156-163 (2008).
15. Paik MJ, Lee J, Kim KR. Simultaneous screening analysis of multiple b-blockers in urine by gas chromatography-mass spectrometry in selected ion monitoring mode. Anal. Chim. Acta 601, 230-233 (2007). (Pubitemid 47498297)
16. Kolmonen M, Leinonen A, Pelander A, Ojanpera I. A general screening method for doping agents in human urine by solid phase extraction and liquid chromatography/time-of-flight mass spectrometry. Anal. Chim. Acta 585, 94-102 (2007). (Pubitemid 46176794)
17. Umezawa H, Lee XP, Arima Y, et al. Simultaneous determination of b-blockers in human plasma using liquid chromatography-tandem mass spectrometry. Biomed. Chromatogr. 22, 702-711 (2008).
18. Jack DB, Dean S, Kendall MJ. Detection of some antihypertensive drugs and their metabolites in urine by thin-layer chromatography: five commonly used b blockers and hydralazine. J. Chromatogr. A 187, 277-280 (1980). (Pubitemid 10136992)
19. Zhang Y, Wu HL, Xia AL, Zhu SH, Han QJ, Yu RQ. Fluorescence determination of metoprolol in human plasma by trilinear decomposition-based calibration techniques. Anal. Bioanal. Chem. 386, 1741-1748 (2006).
20. Salinas-Castillo A, Canabate-Diaz B, Segura-Carretero A, Fernandez-Gutierrez A. Room-temperature, phosphorimetric determination of the b-blocking agent pindolol in pharmaceutical tablets, urine and blood serum. Anal. Bioanal. Chem. 387, 1945-1948 (2007).
21. Zhou X, Li X, Zeng Z. Solid phase micro extraction coupled with capillary electrophoresis for the determination of propranolol enantiomers in urine using sol- gel derived calix[4]arene fibre. J. Chromatogr. A 1104, 359-365 (2006). (Pubitemid 43102578)
22. Akbay C, Rizvi SAA, Shamsi SA. Simultaneous enantioseparation and tandem UV?MS detection of eight b-blockers in micellar electrokinetic chromatography using a chiral molecular micelle. Anal. Chem. 77, 1672-1683 (2005). (Pubitemid 40396260)
23. Paik MJ, Nguyen DT, Kim KR. N-menthoxycarbonylation combined with trimethylsilylation for enantioseparation of b-blockers by achiral dual-column gas chromatography. J. Chromatogr. A 1103, 177-181 (2006).
24. Ranta VP, Toropainen E, Talvitie A, Auriola S, Urtti A. Simultaneous determination of eight b-blockers by gradient high performance liquid chromatography with combined ultraviolet and fluorescence detection in corneal permeability studies in vitro. J. Chromatogr. B 772, 81-87 (2002). (Pubitemid 34450755)
25. Ghanem A, Hoenen H, Aboul-Enein HY. Application and comparison of immobilized and coated amylase tris-(3,5- dimethylphenylcarbamate) chiral stationary phases for the enantioselective separation of b-blockers enantiomers by liquid chromatography. Talanta 68, 602-609 (2006). (Pubitemid 43052460)
26. Delamoye M, Duverneuil C, Paraire F, Mazancourt P, Alvarez JC. Simultaneous determination of thirteen b-blockers and one metabolite by gradient high-performance liquid chromatography with photodiode-array UV detection. Forensic Sci. Int. 141, 23-31 (2004). (Pubitemid 38446833)
27. Maguregui MI, Alonso RM, Jimenez RM. High-performance liquid chromatography with amperometric detection applied to the screening of b-blockers in human urine. J. Chromatogr. B 674, 85-91 (1995).
28. Josefsson M, Sabanovic A. Sample preparation on polymeric solid phase extraction sorbents for liquid chromatographic-tandem mass spectrometric analysis of human whole blood - a study on a number of b-agonists and b-antagonists. J. Chromatogr. A 1120, 1-12 (2006). (Pubitemid 43866770)
29. Chen J, Hsieh Y, Cook J, Morrison R, Korfmacher WA. Supercritical fluid chromatography tandem mass spectrometry for the enantioselective determination of propranolol and pindolol in mouse blood by serial sampling. Anal. Chem. 78, 1212-1217 (2006). (Pubitemid 43271853)
30. Kovarik P, Grivet C, Bourgogne E, Hopfgartner G. Method development aspects for the quantitation of pharmaceutical compounds in human plasma with a matrix-assisted laser desorption/ionization source in the multiple reaction monitoring mode. Rapid Commun. Mass Spectrom. 21, 911-919 (2007). (Pubitemid 46426810)
31. Li S, Liu G, Jia J, et al. Simultaneous determination of ten antiarrhythic drugs and a metabolite in human plasma by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 847, 174-181 (2007). (Pubitemid 46331021)
32. Gergov M, Ojanpera I, Vuori E. Simultaneous screening for 238 drugs in blood by liquid chromatography-ion spray tandem mass spectrometry with multiple-reaction monitoring. J. Chromatogr. B 795, 41-53 (2003). (Pubitemid 37289424)
33. Melwanki MB, Huanga SD, Fuh MR. Three-phase solvent bar micro-extraction and determination of trace amounts of clenbuterol in human urine by liquid chromatography and electrospray tandem mass spectrometry. Talanta 72, 373-377 (2007). (Pubitemid 46550589)
34. Ho TS, Reubsaet JLE, Anthonsen HS, Bjergaard SP, Rasmussen KE. Liquid-phase micro-extraction based on carrier mediated transport combined with liquid chromatography-mass spectrometry. New concept for the determination of polar drugs in a single drop of human plasma. J. Chromatogr. A 1072, 29-36 (2005). (Pubitemid 40488216)
35. Pedersen-Bjergaard S, Rasmussen KE. Bioanalysis of drugs by liquid-phase micro-extraction coupled to separation techniques. J. Chromatogr. B 817, 3-12 (2005). (Pubitemid 40174786)
36. Xu L, Basheer C, Lee HK. Chemical reactions in liquid-phase microextraction. J. Chromatogr. A 1216, 701-707 (2009).
37. Xu, L, Lee HK. Solvent-bar microextraction-using a silica monolith as the extractant phase holder. J. Chromatogr. A 1216, 5483-5488 (2009).
38. Rasmussen KE, Pedersen-Bjergaard S. Developments in hollow fibre based, liquid-phase micro extraction. Trends Anal. Chem. 23, 1-10 (2004). (Pubitemid 38068419)
39. Toda N. Vasodilating b-adrenoceptor blockers as cardiovascular therapeutics. Pharmacol. Ther. 100, 215-234 (2003). (Pubitemid 37494907)
40. Jiang H, Randlett C, Junga H, Jiang X, Ji QC. Using supported liquid extraction together with cellobiohydrolase chiral stationary phases-based liquid chromatography with tandem mass spectrometry for enantioselective determination of acebutolol and its active metabolite diacetolol in spiked human plasma. J. Chromatogr. B 877, 173-180 (2009).
41. Jiang H, Jiang X, Ji QC. Enantioselective determination of alprenolol in human plasma by liquid chromatography with tandem mass spectrometry using cellobiohydrolase chiral stationary phases. J. Chromatogr. B 872, 121-127 (2008).
42. Gwak HS, Noh ES, Lee NY, Chun IK. Determination of amosulalol in human plasma using solid-phase extraction combined with liquid chromatography and ultraviolet detection. J. Chromatogr. B 818, 109-113 (2005). (Pubitemid 40331814)
43. Aboul-Enein HY, Hefnawy MM. Enantioselective determination of arotinolol in human plasma by HPLC using teicoplanin chiral stationary phase. Biomed. Chromatogr. 17, 453-457 (2003). (Pubitemid 37407001)
44. Khuroo A, Mishra S, Singh O, Saxena S, Monif T. Simultaneous determination of atenolol and chlorthalidone by LC-MS/MS in human plasma. Chromatographia 68, 721-729 (2008).
45. Dong L, Huang J. Determination of atenolol in human plasma by pseudo reversed phase liquid chromatography-tandem mass spectrometry. Chromatographia 64, 583-586 (2006). (Pubitemid 44914992)
46. Orazio GD, Fanali S. Use of teicoplanin stationary phase for the enantiomeric resolution of atenolol in human urine by nano-liquid chromatography-mass spectrometry. J. Pharm. Biomed. Anal. 40, 539-544 (2006). (Pubitemid 43227376)
47. Li W, Li Y, Francisco DT, Naidong W. Hydrophilic interaction liquid chromatographic tandem mass spectrometric determination of atenolol in human plasma. Biomed. Chromatogr. 19, 385-393 (2005). (Pubitemid 40990730)
48. Ding L, Zhou X, Gao X, Song Q, He J, Xu G. LC-ESI-MS method for the determination of bisoprolol in human plasma. J. Pharm. Biomed. Anal. 44, 520-525 (2007). (Pubitemid 46880099)
49. Tutunji MF, Ibrahim HM, Khabbas MH, Tutunji LF. Simultaneous determination of bisoprolol and hydrochlorothiazide in human plasma by HPLC coupled with tandem mass spectrometry. J. Chromatogr. B 877, 1689-1697 (2009).
50. Bhatt J, Subbaiah G, Kambli S, et al. A high throughput and sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the estimation of bisoprolol in human plasma using multiplexing technique. J. Chromatogr. B 852, 374-381 (2007). (Pubitemid 46830131)
51. Hefnawy MM, Sultan MAA, Al-Shehri MM. Enantioanalysis of bisoprolol in human plasma with a macrocyclic antibiotic HPLC chiral column using fluorescence detection and solid phase extraction. Chem. Pharm. Bull. 55, 227-230 (2007).
52. Jeong DW, Kim YH, Ji HY, Youn YS, Lee CL, Lee HS. Analysis of carvediol in human plasma using hydrophilic interaction liquid chromatography with tandem mass spectrometry. J. Pharm. Biomed. Anal. 44, 547-552 (2007). (Pubitemid 46887635)
53. Zarghi A, Foroutan SM, Shafaati A, Khoddam A. Quantification of carvedilol in human plasma by liquid chromatography using fluorescence detection. Application in pharmacokinetic studies. J. Pharm. Biomed. Anal. 44, 250-253 (2007). (Pubitemid 46551580)
54. Medvedovici A, Albu F, Georgita C, et al. Achiral-chiral LC/LC-FLD coupling for determination of carvedilol in plasma samples for bioequivalence purposes. J. Chromatogr. B 850, 327-335 (2007). (Pubitemid 46618178)
55. Borges NCC, Mendes GD, Silva DO, Rezende VM, Barrientos-Astigarraga RE, Nucci GD. Quantification of carvedilol in human plasma by high-performance liquid chromatography coupled to electrospray tandem mass spectrometry. Application to bioequivalence study. J. Chromatogr. B 822, 253-262 (2005). (Pubitemid 40994059)
56. Gomes NA, Vaidya VV, Pudage AM, Joshi SS, Parekh SA, Tamhankar AV. Application of a sensitive, rapid and validated LC-MS/MS method for the determination of carvedilol in human plasma. Chromatographia 69, 19-25 (2009).
57. Lamprecht G, Stoschitzky K. Determination of carvedilol in human plasma by high performance liquid chromatography applying on-line deproteination and column switching. Chromatographia 59, 551-554 (2004). (Pubitemid 38757146)
58. Myung SW, Jo CH. Gas chromatograph-mass spectrometric method for the determination of carvedilol and its metabolites in human urine. J. Chromatogr. B 822, 70-77 (2005).
59. Saito M, Kawana J, Ohno T, et al. Enantioselective and highly sensitive determination of carvedilol in human plasma and whole blood after administration of the racemate using normal-phase high-performance liquid chromatography. J. Chromatogr. B 843, 73-77 (2006). (Pubitemid 44512246)
60. Yang E, Wang S, Kratz J, Cyronak MJ. Stereoselective analysis of carvedilol in human plasma using HPLC/MS/MS after chiral derivatization. J. Pharm. Biomed. Anal. 36, 609-615 (2004). (Pubitemid 39441333)
61. Rathod R, Prasad LPC, Rani S, Nivsarkar M, Padh H. Estimation of carvedilol in human plasma by using HPLC-fluorescence detector and its application to pharmacokinetic study. J. Chromatogr. B 857, 219-223 (2007). (Pubitemid 47454566)
62. Tang YH, He Y, Yao TW, Zeng S. Simultaneous determination of the enantiomers of esmolol and its acid metabolite in human plasma by reversed phase liquid chromatography with solid phase extraction. J. Chromatogr. B 805, 249-254 (2004). (Pubitemid 38596744)
63. HashimotoY, Nago S, Tsunekawa M, Shibakawa K, Miyata Y. Validation of HPLC-UV methods for quantitatively determining landiolol and its major metabolite in human blood. Biol. Pharm. Bull. 32, 121-125 (2009).
64. Suno M, Kunisawa T, Yamagishi A, et al. Detection of landiolol using high-performance liquid chromatography/fluorescence: a blood esterase-sensitive ultra-short acting b1-receptor antagonist. J. Chromatogr. B 877, 1705-1708 (2009).
65. Selvan PS, Pal TK. Chromatography-tandem mass spectrometry method for the simultaneous quantitation of metoprolol succinate and simvastatin in human plasma. J. Pharm. Biomed. Anal. 49, 780-785 (2009).
66. Jensen BP, Sharp CF, Gardiner SJ, Begg EJ. Development and validation of a stereoselective liquid chromatography- tandem mass spectrometry assay for quantification of S- and R- metoprolol in human plasma. J. Chromatogr. B 865, 48-54 (2008).
67. Sarkar AK, Ghosh D, Das A, et al. Simultaneous determination of metoprolol succinate and amlodipine besylate in human plasma by liquid chromatography-tandem mass spectrometry method and its application in bioequivalence study. J. Chromatogr. B 873, 77-85 (2008).
68. Gowda KV, Mandal U, Selvan PS, et al. Liquid chromatography tandem mass spectrometry method for simultaneous determination of metoprolol tartrate and ramipril in human plasma. J. Chromatogr. B 858, 13-21 (2007). (Pubitemid 47513592)
69. Albers S, Elshoff JP, Völker C, Richter A, Läer S. HPLC quantification of metoprolol with solid-phase extraction for the drug monitoring of pediatric patients. Biomed. Chromatogr. 19, 202-207 (2005). (Pubitemid 40528586)
70. Ramakrishna NVS, Vishwottam KN, Koteshwara M, Manoj S, Santosh M, Varma DP. Rapid quantification of nebivolol in human plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometry. J. Pharm. Biomed. Anal. 39, 1006-1013 (2005). (Pubitemid 41441730)
71. Selvan PS, Gowda KV, Mandal U, Soloman WDS, Pal TK. Simultaneous determination of fixed dose combination of nebivolol and valsartan in human plasma by liquid chromatographic-tandem mass spectrometry and its application to pharmacokinetic study. J. Chromatogr. B 858, 143-150 (2007). (Pubitemid 47513603)
72. Rossi AD, Desiderio C. High sensitivity analysis of oxeprenolol in urine by capillary electrophoresis with C18 packed on-line preconcentrator. J. Chromatogr. B 839, 6-11 (2007). (Pubitemid 44037515)
73. Abdel-Rehim M, Persson C, Altun Z, Blomberg L. Evaluation of monolithic packed 96-tips and liquid chromatography- tandem mass spectrometry for extraction and quantification of pindolol and metoprolol in human plasma samples. J. Chromatogr. A 1196-1197, 23-27 (2007).
74. Wang H, Shen Z. Enantiomeric separation and quantification of pindolol in human plasma by chiral liquid chromatography/tandem mass spectrometry using staggered injection with a CTC trio valve system. Rapid Commun. Mass Spectrom. 20, 291-297 (2006). (Pubitemid 43121633)
75. Siluk D, Mager DE, Gronich N, Abernethy D, Wainer IW. HPLC-atmospheric pressure chemical ionization mass spectrometric method for enantioselective determination of R,S-propranolol and R,S-hyoscyamine in human plasma. J. Chromatogr. B 859, 213-221 (2007). (Pubitemid 350046455)
76. Nevado JJB, Flores JR, Penalvo GC, Bernardo FJG. Development and validation of a capillary zone electrophoresis method for the determination of propranolol and N-desisopropylpranolol in human urine. Anal. Chim. Acta 559, 9-14 (2006). (Pubitemid 43184281)
77. Silva LC, Trevisan MG, Poppi RJ, Sena MM. Direct determination of propranolol in urine by pectrofluorimetry with the aid of second order advantage. Anal. Chim. Acta 595, 282-288 (2007). (Pubitemid 46990288)
78. Satinsky D, Serralheiro HS, Solich P, Araujo AN, Montenegro MC. On-line coupling of sequential injection extraction with restricted-access materials and post-column derivatization for sample clean-up and determination of propranolol in human plasma. Anal. Chim. Acta 600, 122-128 (2007). (Pubitemid 47445425)
79. Zarghi A, Foroutan SM, Shafaati A, Khoddam A. Development of ion-pair liquid chromatographic method for determination of sotalol in plasma using a monolithic column. J. Pharm. Biomed. Anal. 41, 1433-1437 (2006). (Pubitemid 43775896)
80. He J, Bernd T, Yang LY, et al. Determination of talinolol in human plasma by high performance liquid chromatography-electrospray ionization mass spectrometry: application to pharmacokinetic study. J. Chromatogr. B 853, 275-280 (2007). (Pubitemid 46891372)
81. Bourgogne E, Grivet C, Hopfgartner G. Determination of talinolol in human plasma using automated on-line solid phase extraction combined with atmospheric chemical ionization tandem mass spectrometry. J. Chromatogr. B 820, 103-110 (2005). (Pubitemid 40615443)
82. WADA 2009 prohibited list www.wada-ama.org/rtecontent/document/2009- Prohibited-List-ENG- Final-20-Sept-08.pdf (Accessed September 2009).
83. WADA minimum required performance limits for detection of prohibited substances www.wada-ama.org/rtecontent/document/perf-limits-2.pdf (Accessed September 2009).
84. Wikipedia. Pharmacological information regarding levobunolol, mepindolol, metipranolol, practolol, tertatolol and tilisolol http://en.wikipedia.org/wiki/